5 PhD Students in Immunology and Vaccine Development (f/m/d)
65% positions at the earliest possible date until 30 June 2025, with a possibility of extension.
As part of the excellence University of Tübingen, Tübingen University Hospital (UKT) is one of the leading university hospitals in Europe contributing to high-performance medicine, research and teaching. Within the University Hospital, the Institute of Tropical Medicine and the Department of Immunology share a major focus on Vaccine Development and Translational Immunology. Tuebingen is a university town located in the south of Germany of about 90,000 inhabitants and 28,000 students that combines the flair of a lovingly restored medieval center with the colorful bustle and typical atmosphere of a young and cosmopolitan student’s town.
You finished college with a Master’s degree in Biology, Biochemistry or Molecular Medicine and are looking to make your first step in your future scientific career? You are motivated to find and develop novel, innovative vaccines to fight cancer and severe infectious diseases such as Tuberculosis, Dengue and RSV? We, that means the Institute of Tropical Medicine and the Department of Immunology, offer five PhD positions in the field of virus vector-based vaccines and therapeutics. Join us in further advancing our vaccine technology and bringing it to the next level in order to meet escalating health care challenges!
Recently, the UKT in partnership with Prime Vector Technologies advanced a vaccine candidate based on the Orf virus (ORFV) platform technology from research and early development into clinical trials. The results of these studies have positioned this technology at the forefront of viral vector-based vaccine and therapy platforms. To exploit the full potential of this highly promising vaccine technology, we are looking for highly motivated candidates interested in the following topics
Find out more and apply online.
